Literature DB >> 2844456

Soluble Tac peptide is present in the urine of normal individuals and at elevated levels in patients with adult T cell leukaemia (ATL).

L Marcon1, M E Fritz, C C Kurman, J C Jensen, D L Nelson.   

Abstract

The T lymphocyte-derived lymphokine interleukin 2 and the cell-associated receptor for this molecule play major roles in the activation and regulation of the human immune response. An enzyme-linked immunosorbent assay has been developed to measure quantitatively a soluble form of one component of the human interleukin 2 receptor, namely the Tac peptide. In the present studies, soluble Tac peptide was measured in the urine of normal individuals (mean = 92 U/ml), a level not significantly different (0.01 less than P less than 0.05) from the corresponding serum concentrations (mean = 175). The urinary Tac peptide had a molecular weight of 40-45 kD by sodium dodecyl sulphate-polyacrylamide gel electrophoresis analysis and specifically bound interleukin 2. Elevated levels of urinary Tac peptide were found in four patients with adult T cell leukaemia who also had elevated serum levels of Tac peptide. Thus, urine may represent a valuable source of lymphokine-binding proteins that may serve as important markers of immunological activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844456      PMCID: PMC1541464     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

2.  Automated high-performance immunosorbent assay for recombinant leukocyte A interferon.

Authors:  S K Roy; W C McGregor; S T Orichowskyj
Journal:  J Chromatogr       Date:  1985-06-26

3.  A monoclonal antibody 7G7/B6, binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac.

Authors:  L A Rubin; C C Kurman; W E Biddison; N D Goldman; D L Nelson
Journal:  Hybridoma       Date:  1985

4.  Uromodulin: a unique 85-kilodalton immunosuppressive glycoprotein isolated from urine of pregnant women.

Authors:  A V Muchmore; J M Decker
Journal:  Science       Date:  1985-08-02       Impact factor: 47.728

5.  A thymocyte-activating factor derived from glomerular mesangial cells.

Authors:  D H Lovett; J L Ryan; R B Sterzel
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

6.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Kinetics, competition, and selectivity of tubular absorption of proteins.

Authors:  B E Sumpio; T Maack
Journal:  Am J Physiol       Date:  1982-10

8.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

9.  Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.

Authors:  F Herrmann; S A Cannistra; H Levine; J D Griffin
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

10.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

View more
  13 in total

Review 1.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

2.  Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.

Authors:  S Horiuchi; Y Koyanagi; Y Tanaka; M Waki; A Matsumoto; Y W Zhou; M Yamamoto; N Yamamoto
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Urinary excretion of CD23 antigen in normal individuals and patients with chronic lymphocytic leukaemia (CLL)

Authors:  N R Ling; F K Stevenson; B Brown
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

4.  Serum and urine soluble interleukin-2 receptor in idiopathic nephrotic syndrome.

Authors:  G H Bock; J R Ongkingco; L T Patterson; J Ruley; L R Schroepfer; D L Nelson
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

5.  Pitfalls in the measurement of soluble forms of cell surface receptors.

Authors:  N R Ling
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis.

Authors:  C Y Tsai; T H Wu; K H Sun; W M Lin; C L Yu
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

7.  A disturbance of the IL-2/IL-2 receptor system parallels the activity of multiple myeloma.

Authors:  A Vacca; R Di Stefano; A Frassanito; G Iodice; F Dammacco
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

8.  Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Authors:  R P Junghans; T A Waldmann
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit.

Authors:  J Tavernier; T Tuypens; G Plaetinck; A Verhee; W Fiers; R Devos
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.

Authors:  J Brynskov; N Tvede
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.